PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Global Bioenergies SA (ALGBE.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0011052257
SectorUtilities
IndustryUtilities - Diversified

Highlights

Market Cap€28.34M
EPS (TTM)-€0.48
Total Revenue (TTM)€147.33K
Gross Profit (TTM)-€4.52M
EBITDA (TTM)-€6.46M
Year Range€1.40 - €2.76
Target Price€3.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Global Bioenergies SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%500.00%AprilMayJuneJulyAugustSeptember
-94.31%
468.45%
ALGBE.PA (Global Bioenergies SA)
Benchmark (^GSPC)

Returns By Period

Global Bioenergies SA had a return of -22.57% year-to-date (YTD) and -43.44% in the last 12 months. Over the past 10 years, Global Bioenergies SA had an annualized return of -27.48%, while the S&P 500 had an annualized return of 10.92%, indicating that Global Bioenergies SA did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-22.57%17.95%
1 month-8.00%3.13%
6 months-16.36%9.95%
1 year-43.44%24.88%
5 years (annualized)-16.51%13.37%
10 years (annualized)-27.48%10.92%

Monthly Returns

The table below presents the monthly returns of ALGBE.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.27%-1.74%-4.06%-1.19%8.79%-29.19%31.10%-6.20%-22.57%
20232.01%-10.00%-19.33%-8.26%96.50%-18.32%-3.43%5.32%-32.31%-7.69%0.00%-0.98%-31.38%
20226.46%-10.06%7.17%-6.00%-5.34%-14.82%3.38%10.30%-17.08%17.17%-9.26%-22.74%-39.60%
20210.26%-15.84%6.79%-5.20%-6.25%4.88%-3.41%-7.22%1.73%-11.40%7.29%-11.45%-35.55%
20206.18%-29.87%-22.74%49.53%-10.31%13.24%19.08%-11.63%-19.88%8.03%102.70%28.00%106.45%
20190.82%1.13%-18.37%-7.73%-9.33%0.70%-2.44%-2.38%-23.54%-16.75%-6.90%53.08%-39.41%
201821.02%-2.32%1.30%-4.27%-8.03%-6.18%-19.25%9.76%-18.37%-23.21%-15.12%-15.89%-60.77%
20173.85%-6.29%-3.79%-10.29%-0.50%-12.28%-11.60%23.46%-16.23%-1.94%5.54%-5.50%-34.44%
2016-5.44%-22.92%0.87%27.81%-18.62%34.16%7.14%-4.84%1.32%-2.01%-16.73%8.75%-5.95%
2015-3.76%23.67%5.37%2.04%46.93%-17.18%9.38%-12.56%-11.79%-1.39%-12.77%-18.00%-7.34%
201465.07%-10.93%14.57%-10.57%-3.37%-3.97%1.95%0.42%6.54%-11.05%1.31%-29.32%-2.87%
20136.88%1.32%0.33%-5.00%-1.40%6.69%-10.37%-1.38%-5.96%7.83%-3.80%9.09%2.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALGBE.PA is 10, indicating that it is in the bottom 10% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALGBE.PA is 1010
ALGBE.PA (Global Bioenergies SA)
The Sharpe Ratio Rank of ALGBE.PA is 66Sharpe Ratio Rank
The Sortino Ratio Rank of ALGBE.PA is 77Sortino Ratio Rank
The Omega Ratio Rank of ALGBE.PA is 99Omega Ratio Rank
The Calmar Ratio Rank of ALGBE.PA is 2323Calmar Ratio Rank
The Martin Ratio Rank of ALGBE.PA is 66Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Global Bioenergies SA (ALGBE.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALGBE.PA
Sharpe ratio
The chart of Sharpe ratio for ALGBE.PA, currently valued at -0.95, compared to the broader market-4.00-2.000.002.00-0.95
Sortino ratio
The chart of Sortino ratio for ALGBE.PA, currently valued at -1.50, compared to the broader market-6.00-4.00-2.000.002.004.00-1.50
Omega ratio
The chart of Omega ratio for ALGBE.PA, currently valued at 0.82, compared to the broader market0.501.001.502.000.82
Calmar ratio
The chart of Calmar ratio for ALGBE.PA, currently valued at -0.44, compared to the broader market0.001.002.003.004.005.00-0.44
Martin ratio
The chart of Martin ratio for ALGBE.PA, currently valued at -1.58, compared to the broader market-10.00-5.000.005.0010.0015.0020.00-1.58
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.03, compared to the broader market-4.00-2.000.002.002.03
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.74, compared to the broader market-6.00-4.00-2.000.002.004.002.74
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.502.001.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.83, compared to the broader market0.001.002.003.004.005.001.83
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.70, compared to the broader market-10.00-5.000.005.0010.0015.0020.009.70

Sharpe Ratio

The current Global Bioenergies SA Sharpe ratio is -0.95. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Global Bioenergies SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
-0.95
1.74
ALGBE.PA (Global Bioenergies SA)
Benchmark (^GSPC)

Dividends

Dividend History


Global Bioenergies SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-97.31%
-2.37%
ALGBE.PA (Global Bioenergies SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Global Bioenergies SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Global Bioenergies SA was 97.59%, occurring on Jun 28, 2024. The portfolio has not yet recovered.

The current Global Bioenergies SA drawdown is 97.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.59%May 27, 20152330Jun 28, 2024
-45.31%Apr 2, 2014189Dec 29, 201496May 18, 2015285
-45.28%Jun 16, 2011131Dec 15, 2011253Dec 10, 2012384
-25.23%Jun 21, 201361Sep 13, 201389Jan 21, 2014150
-16.48%Dec 13, 20124Dec 18, 2012125Jun 19, 2013129

Volatility

Volatility Chart

The current Global Bioenergies SA volatility is 10.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
10.06%
4.38%
ALGBE.PA (Global Bioenergies SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Global Bioenergies SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Global Bioenergies SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items